Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 1;396(1):23-9.
doi: 10.1016/j.ab.2009.08.022. Epub 2009 Aug 21.

Quantification of extracellular UDP-galactose

Affiliations

Quantification of extracellular UDP-galactose

Eduardo R Lazarowski. Anal Biochem. .

Abstract

The human P2Y(14) receptor is potently activated by UDP-glucose (UDP-Glc), UDP-galactose (UDP-Gal), UDP-N-acetylglucosamine (UDP-GlcNAc), and UDP-glucuronic acid. Recently, cellular release of UDP-Glc and UDP-GlcNAc has been reported, but whether additional UDP-sugars are endogenous agonists for the P2Y(14) receptor remains poorly defined. In the present study, we describe an assay for the quantification of UDP-Gal with subnanomolar sensitivity. This assay is based on the enzymatic conversion of UDP-Gal to UDP, using 1-4-beta-galactosyltransferase. UDP is subsequently phosphorylated by nucleoside diphosphokinase in the presence of [gamma-(32)P]ATP and the formation of [gamma-(32)P]UTP is monitored by high-performance liquid chromatography. The overall conversion of UDP-Gal to [gamma-(32)P]UTP was linear between 0.5 and 30 nM UDP-Gal. Extracellular UDP-Gal was detected on resting cultures of various cell types, and increased release of UDP-Gal was observed in 1321N1 human astrocytoma cells stimulated with the protease-activated receptor agonist thrombin. The occurrence of regulated release of UDP-Gal suggests that, in addition to its role in glycosylation reactions, UDP-Gal is an important extracellular signaling molecule.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Enzymatic conversion of UDP-[3H]Gal to [3H]lactose
A, HPLC tracings illustrating the conversion of UDP-[3H]Gal to [3H]lactose ([3H]Lac) in the presence (bottom) or in the absence (top) of 4βGT (0.002 U/ml, 60 min, 30°C). B, incubations were for 60 min at 30°C in the presence of the indicated amount of 4βGT. C, the time-course of the reaction was examined using 0.002 U/ml 4βGT. D, the conversion of UDP-[3H]Gal to [3H]lactose was assessed in the absence (-) or presence (+) of 0.2 mg/ml α-lactalbumin. All reactions were performed in 100 μl DMEM-H containing 20 mM glucose, 100 nM (0.1 μCi) [3H]UDP-Gal, 5 mM MnCl2, and (except as indicated in D) 0.2 mg/ml α-lactalbumin. Radioactive species were separated by HPLC. The data represent the mean ± SD from at least three independent experiments performed in duplicates.
Figure 2
Figure 2. 4βGT-catalized formation of lactose or N-acetyllactosamine
A, UDP-Gal but not UDP-Glc is a substrate of 4βGT. Incubations were as in Figure 1A, in the presence of the indicated concentration of UDP-[3H]Gal or UDP-[3H]Glc. B, effect of N-acetylglucosamine concentration on the conversion of 100 nM (0.1 μCi) UDP-[3H]Gal to [3H]N-acetyllactosamine. Radioactive species were separated by HPLC. The data represent the mean ± SD, n ≥ 3.
Figure 3
Figure 3. Assessing UDP-Gal via UDP phosphorylation
The conversion of [γ32P]ATP to [γ32P]UTP was assessed by HPLC, as detailed in Methods. A, UDP (10 nM) was incubated in the presence of 100 nM (0.2 μCi) [γ32P]ATP and the indicated amount of NDPK. B, time course of the NDPK (0.1 U/ml)-catalyzed phosphorylation of 10 nM UDP in the presence of 100 nM (0.2 μCi) [γ32P]ATP. C, the UDP calibration curve was performed in the presence of 0.1 U/ml NDPK and 100 nM (0.2 μCi) [γ32P]ATP (5 min, 30°C). The reaction was lineal between 0–30 nM UDP (r2 = 0.9996), displaying a slope a value of 0.93784 and an intercept b value of 0.07. D, UDP-Gal (at the indicated concentration) was incubated for 30 min in the absence or presence of 0.002 U/ml 4βGT. At the end of this period, NDPK and [γ32P]ATP were added for 5 min, as detailed in C. The reaction was lineal between 0–30 nM UDP-Gal (a = 1.016, b = 0, and r2 = 0.9998). The data represent the mean ± SD, n ≥ 4. All incubations were performed in 100 μL DMEM-H supplemented with MnCl2 and α-lactalbumin, as indicated in Figure 1. Background radioactivity (i.e., observed in the absence of UDP-Gal and UDP) was subtracted from all data points to allow regression lines fitting to origin.
Figure 4
Figure 4. Enhanced UDP-Gal and UDP-Glc release from thrombin-stimulated 1321N1 human astrocytoma cells
A, cells were rinsed and pre-incubated in 300 μl DMEM-H for 1 h, and thrombin (20 nM) was subsequently added for 5 min. UDP-Gal and UDP-Glc present in the extracellular medium were quantified, as described in Methods. The results represent the main value (± SD) from two independent experiments performed in triplicate; (*) indicates significant differences relative to control (p < 0.01, t-test). B, the stability of extracellular UDP-Gal and UDP-Glc on 1321N1 cells was assessed in cultures spiked with 0.5 μCi of the indicated radiotracer. Samples were collected at the indicated times and the resulting [3H]species were analyzed by HPLC, as described in Methods (mean ± SD, n = 4).

Similar articles

Cited by

References

    1. Burnstock G, Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther. 2000;295:862–869. - PubMed
    1. Burnstock G. Purinergic signalling. Br J Pharmacol. 2006;147(Suppl 1):S172–S181. - PMC - PubMed
    1. Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K, Foley JJ, Zhu Y, McLaughlin MM, Murdock P, McMillan L, Trill J, Swift A, Aiyar N, Taylor P, Vawter L, Naheed S, Szekeres P, Hervieu G, Scott C, Watson JM, Murphy AJ, Duzic E, Klein C, Bergsma DJ, Wilson S, Livi GP. A G protein-coupled receptor for UDP-glucose. J Biol Chem. 2000;275:10767–10771. - PubMed
    1. Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G. Characterization of the UDP-glucose receptor (re-named here the P2Y(14) receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci. 2003;24:52–55. - PMC - PubMed
    1. Fricks IP, Carter RL, Lazarowski ER, Harden TK. Gi-dependent cell signaling responses of the human P2Y14-receptor in model cell systems. J Pharmacol Exp Ther. 2009 in press. - PMC - PubMed

Publication types

LinkOut - more resources